Medical
Female CEOs
Manufacturing

Lantheus

$23.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (0.38%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Lantheus and other stocks, options, ETFs, and crypto commission-free!

About

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. Read More The firm's operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Employees
488
Headquarters
North Billerica, Massachusetts
Founded
1956
Market Cap
908.57M
Price-Earnings Ratio
23.08
Dividend Yield
0.00
Average Volume
326.24K
High Today
$23.83
Low Today
$21.50
Open Price
$23.35
Volume
141.93K
52 Week High
$25.49
52 Week Low
$12.59

Collections

Medical
Female CEOs
Manufacturing
Health
Technology
2015 IPO
US
North America

News

Markets Insider21h

Lantheus Announces Upcoming Retirement of Chief Medical Officer in September 2019 and Promotion of Senior Vice President, Technical Operations to Chief Operations Officer

Lantheus Holdings, Inc. (the "Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. ("LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that Cesare Orlandi, M.D., Chief Medical Officer, will retire from the Company on September 2, 2019. In addition, John Bolla, the Company’s Senior Vice President, Technical Operations, has been promoted to the newly created position of Chief Operations Offic...

10
Yahoo FinanceMar 21

Top Ranked Momentum Stocks to Buy for March 21st

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 21st: Bio-Rad Laboratories, Inc. (BIO): This manufacturer of products and solutions for life science research has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days. Bio-Rad Laboratories, Inc. Price and Consensus Bio-Rad Laboratories, Inc. Price and Consensus More Bio-Rad Laboratories, Inc. price-consensus-c...

169
Yahoo FinanceMar 15

LNTH vs. CLPBY: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Lantheus Holdings (LNTH) or Coloplast A/S (CLPBY). But which of these two stocks is more attractive to value investors?

53

Earnings

$0.12
$0.22
$0.32
$0.42
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.